Raymond James & Associates’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,046
| Closed | -$275K | – | 3853 |
|
|
2022
Q2 | $275K | Sell |
5,046
-9,898
| -66% | -$539K | ﹤0.01% | 3269 |
|
|
2022
Q1 | $933K | Buy |
14,944
+4,486
| +43% | +$280K | ﹤0.01% | 2638 |
|
|
2021
Q4 | $1.05M | Buy |
10,458
+3,113
| +42% | +$313K | ﹤0.01% | 2581 |
|
|
2021
Q3 | $661K | Buy |
7,345
+201
| +3% | +$18.1K | ﹤0.01% | 2853 |
|
|
2021
Q2 | $659K | Sell |
7,144
-9,097
| -56% | -$839K | ﹤0.01% | 2873 |
|
|
2021
Q1 | $1.57M | Sell |
16,241
-4,208
| -21% | -$407K | ﹤0.01% | 2180 |
|
|
2020
Q4 | $1.07M | Buy |
20,449
+5,199
| +34% | +$271K | ﹤0.01% | 2295 |
|
|
2020
Q3 | $611K | Sell |
15,250
-12,170
| -44% | -$488K | ﹤0.01% | 2477 |
|
|
2020
Q2 | $439K | Buy |
27,420
+14,585
| +114% | +$234K | ﹤0.01% | 2663 |
|
|
2020
Q1 | $138K | Sell |
12,835
-2,070
| -14% | -$22.3K | ﹤0.01% | 3125 |
|
|
2019
Q4 | $192K | Buy |
+14,905
| New | +$192K | ﹤0.01% | 3330 |
|